PLUS1
57.49
1.63 (2.92%)
1.63 (2.92%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Invitae Corporation | NVTA | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.63 | 2.92% | 57.49 | 15:36:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 57.10 | 56.765 | 60.2499 | 55.86 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 33,523 | 3,033,921 | $ 57.99 | $ 175,935,571 | 4,837,685 | 7.415 - 61.59 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:36:40 | 27 | $ 57.4564 | USD |
Invitae Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 10.16B | 176.70M | 176.08M | $ 216.82M | $ - | -2.63 | -13.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Invitae News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/14/2021 | 07:30 | PR Newswire (US) | Leading Biopharmaceutical Companies Select Invitae to.. |
| 1/13/2021 | 08:02 | GlobeNewswire Inc. | Pacific Biosciences and Invitae to Develop.. |
| 1/11/2021 | 07:30 | PR Newswire (US) | Invitae Reports Preliminary 2020 Financial Results of More.. |
| 1/08/2021 | 17:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/29/2020 | 07:30 | PR Newswire (US) | Invitae to Present at the 39th Annual J.P. Morgan Healthcare.. |
| 12/23/2020 | 17:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/23/2020 | 17:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVTA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 48.46 | 60.2499 | 48.10 | 53.03 | 4,637,510 | 9.03 | 18.63% |
| 1 Month | 53.65 | 60.2499 | 41.31 | 47.96 | 4,494,255 | 3.84 | 7.16% |
| 3 Months | 46.50 | 61.59 | 38.3844 | 48.31 | 3,889,077 | 10.99 | 23.63% |
| 6 Months | 32.89 | 61.59 | 27.47 | 43.82 | 3,184,471 | 24.60 | 74.79% |
| 1 Year | 19.50 | 61.59 | 7.415 | 31.72 | 3,283,303 | 37.99 | 194.82% |
| 3 Years | 7.18 | 61.59 | 4.35 | 25.00 | 2,063,712 | 50.31 | 700.7% |
| 5 Years | 6.84 | 61.59 | 4.35 | 23.79 | 1,337,180 | 50.65 | 740.5% |
Invitae Description
| Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. |
